UNH
59
2
BF.B
59
2
MDLZ
73
2
CRM
59
2
CAG
37
3
PX
52
2
EMN
66
3
STX
59
6
APD
44
4
SIG
57
7
NI
67
2
STT
42
2
BMY
63
7
MRK
45
4
DHI
68
12
OKE
70
3
USB
42
2
GD
62
2
DE
50
2
SEE
30
-11
UNH
59
2
BF.B
59
2
MDLZ
73
2
CRM
59
2
CAG
37
3
PX
52
2
EMN
66
3
STX
59
6
APD
44
4
SIG
57
7
NI
67
2
STT
42
2
BMY
63
7
MRK
45
4
DHI
68
12
OKE
70
3
USB
42
2
GD
62
2
DE
50
2
SEE
30
-11
Financhill
Back

Armata Pharmaceuticals 10K Form

Sell
32

ARMP
Armata Pharmaceuticals

Last Price:
2.20
Seasonality Move:
1.74%

7 Day Trial

ALL ACCESS PASS

$ 7

Key Filings

10K form not available

Receive ARMP News And Ratings

See the #1 stock for the next 7 days that we like better than ARMP

ARMP Financial Statistics

Sales & Book Value

Annual Sales: $820K
Cash Flow: $-11.54M
Price / Cash Flow: 0
Annual Sales: $-1.28
Price / Book: 0

Profitability

EPS (TTM): -2.35000
Net Income (TTM): $-67.04M
Gross Margin: $410K
Return on Equity: 0%
Return on Assets: 0%

Armata Pharmaceuticals Earnings Forecast

Key Armata Pharmaceuticals Financial Ratios

  • The Gross Profit Margin over the past 19 years for ARMP is 100.24%.
  • The Selling, General & Administrative Expenses for ARMP have been equal to 971.46% of Gross Profit Margin.
  • The Interest Expense is -3.80% of Operating Income.
  • Per Share Earnings over the last 28 years have been positive in 11 years.

Armata Pharmaceuticals Stock Price Chart

Industry, Sector and Symbol

Stock Exchange: NYAM
Industry: Biotechnology
Sector: Health Care
Current Symbol: ARMP
CUSIP: 04216R
Website: armatapharma.com

Debt

Debt-to-Equity Ratio: 0
Current Ratio: 0
Quick Ratio: 0

Price-to-Earnings

Trailing P/E Ratio: 0
Forward P/E Ratio: 0

ARMP Technical Analysis vs Fundamental Analysis

Sell
32
Armata Pharmaceuticals (ARMP) is a Sell

Is Armata Pharmaceuticals a Buy or a Sell?